Daimon S. et al., Goodpasture’s-like syndrome and effect of extracorporeal membrane oxygenator support. Intern Med 33: 569-73, 1994
Daimon S. et al., Antineutrophil cytoplasmic antibody-positive rapidly progressive glomerulonephritis caused by propylthiouracil. Clin Exper Nephrol 1: 225-228, 1997
Daimon S. and Koni I., Glomerular enlargement in the progression of mesangial proliferative glomerulonephritis. Clin Nephrol 49: 145-52, 1998
Daimon S. et al., Infective endocarditis-induced crescentic glomerulonephritis dramatically improved by plasmapheresis. Am J Kidney Dis 32: 309-13, 1998
Daimon S. et al., Efficacy of extracorporeal ultrafultration of ascetic fluid as a treatment of refractory ascites.Nephrol Dial Transplant 13: 2617-23, 1998
Daimon S. et al., Dextran sulphate cellulose columns for the treatment of nephritic syndrome due to inactive lupus nephritis.Nephrol Dial Transplant 15: 235-8, 2000
Daimon S. et al., LDL-apheresis followed by corticosteroid therapy as a possible treatment of cholesterol crystal embolism. Clin Exper Nephrol 4: 352-5, 2000
Daimon S. and Terai H.,Influence of Antiplatelet Medications on Bleeding Events in Hemodialysis Patients. Ther Apher Dial 15(5): 454-9, 2011
Daimon S. et al., Comparison of acetate-free citrate hemodialysis and bicarbonate hemodialysis regarding the effect of intra-dialysis hypotension and post-dialysis malaise. Ther Apher Dial 15(5): 460-5, 2011
Daimon S., Antiplatelet medication and the risk of bleeding in hemodialysis patients. In: Yuri F. Cabral, Marina Costa De Santos, ed. Hemodialysis: Indications, Procedures and Complications. Nova Publishers: 151-64, 2012
Daimon S. et al., Efficacy of coronary artery screening tests and intervention in hemodialysis patients. Ther Apher Dial 18(5): 443-9, 2014
Daimon S.,Comparison of the effect of the same dose of a 4-weekly continuous erythropoietin receptor activator administered once every 2 or 4 weeks in hemodialysis patients. Ther Apher Dial 18(5): 518-20, 2014
Daimon S. et al., Influence of continuous erythropoietin receptor activator (C.E.R.A.) administration intervals on erythropoietic effect in hemodialysis patients. Renal Replacement Therapy 2: 58, 2016
Daimon S. and Mizushima I., Effect of oral and intravenous iron therapy on hemoglobin levels in hemodialysis patients according to serum ferritin level. Renal Replacement Therapy 2: 63, 2016
Daimon S. Low dose oral iron as a safe and effective iron administration for anemia treatment in hemodialysis patients. Int J Hematol Ther 4(1): 25-30, 2018
Doi K., Nishitani M. et al., Influence of leakage from non-invasive positive pressure ventilation mask on FiO2 value delivered by home oxygen therapy concentrator: A bench study on stimulating patients with chronic obstructive pulmonary disease. Health 10: 919-27, 2018
Saito YC., Nishitani M. et al., Monoamines inhibit GABAergic neurons in ventroteral preoptic area that make direct synaptic connections to hypothalamic arousal neurons. J Neurosci 38(28): 6366-78, 2018
Doi K., Nishitani M. et al., Outline and issues of internet addiction. Biomed J Sci&Tech Res 6(5), 2018
Daimon S.,Adverse effect of antithrombotic medications on bleeding events and comparison of antithrombotic agents in hemodialysis patients. Ther Apher Dial 23(1): 32-7, 2019
Daimon S., Efficacy for anemia and changes in serum ferritin levels by long-term oral iron administration in hemodialysis patients.Ther Apher Dial 23(5): 444-50, 2019
Daimon S., Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator. Ther Apher Dial 24(5): 602-6, 2020
Daimon S.,Shortened red cell life span as a factor of anemia of mild inflammation in hemodialysis patients. Ther Apher Dial 24(6): 742-4, 2020
Daimon S., Yasuda M., Nishitani M., Serum carnitine concentration and the acyl to free carnitine ratio in nondialysis chronic kidney disease and hemodialysis patients. Ther Apher Dial (in press)
Effect of antithrombotic medications on bleeding events and comparison of antithrombotic agents in hemodialysis patients.Daimon S et al,International Society of Nephrology (ISN) Frontiers Symposium 2018 (Tokyo Feb 22-25)
Antiplatelet medication and the risk of bleeding in hemodialysis patients. Shoichiro Daimon (2012 International Forum on Advances in Vaccines & Preventive Medicine, Whistler, Canada, Mar 16-17)